New Haven biotech DeepLook Medical’s AI-driven imaging software targets better breast cancer detection

New Haven biotech DeepLook Medical’s AI-driven imaging software targets better breast cancer detection

Enter New Haven-based medical technology startup DeepLook Medical. Since its founding in December 2018, DeepLook, based at 470 James St., has developed and secured two patents and FDA clearance for its medical imaging analysis software, called DL Precise. The company, which has raised millions of dollars in venture funding, says its shape-recognition software significantly improves the accuracy and efficiency of medical imaging, and is specifically designed to detect cancer in dense breast tissue. When it was granted its second patent in April, DeepLook stated that its software can leverage medical imaging data to isolate and display the underlying structure of masses in breasts that previously were “obscured, hidden or masked from human vision.” Read more >>

Share this post